When blood hits clothes, physics takes over
Forensic science is a relatively new concept, historically speaking. There are multiple major moments in its development, but the field of study can largely be traced back 115 years ago to a man named Edmond Locard. In 1910, the French criminologist first proposed his theory that 'every contact leaves a trace,' a concept now known as Locard's exchange principle. Those traces come in many forms– including bloodstains. But as Locard's principle implies, traces are also influenced by the conditions of the contact itself.Over a century later, there are many high-tech methods for analyzing a violent crime scene's bloodstains. Forensic scientists gather evidence all the way down to the molecular level, but even a close visual read of the situation often offers invaluable information. For example, bloodstains may indicate the type of weapon, attack angle, and force of impact. However, these patterns are frequently influenced by the surface material's interaction with the blood itself, particularly when that material is clothing made from cotton. According to researchers at North Carolina State University, the results can prove frustrating.
'Textiles have complicated structures and are often absorbent. These characteristics can result in highly distorted bloodstain shapes,' the team wrote in their study, adding that 'complex stain characteristics can make bloodstain pattern analysis more challenging and less straightforward.'
'When blood strikes fabric, it leaves a stain. But it can be difficult to accurately assess things like how quickly blood was traveling when it struck the fabric,' Tiegang Fang, one of the study's corresponding authors and an NC State mechanical and aerospace professor, said in a statement. 'Was it going fast? Slow? Did someone just brush up against the blood? It's hard to tell, because once the blood comes into contact with the fabric, it wicks across the surface of the fibers in the fabric, spreading out.'
This process frequently also creates thin tendrils known as 'fingers' that extend from a bloodstain's center, further complicating analysis. To study these and other attributes, Fang and colleagues used pig's blood treated to behave consistently across testing. They then lined up five cotton fabrics—plain-woven cotton, the front and back of cotton twill, as well as the front and back of a jersey knit. Next, the team used multiple high-speed cameras to capture the fabrics at four frames per second, splattering the textile samples at 12 different velocities. They reviewed the footage of their messes, and soon noticed the particular behavior of each stain's fingers.
'We found that the more fingers a bloodstain has, the faster the blood was moving when it struck the fabric,' said Fang. 'However, over time, these fingers may spread out and run together.'
Another major velocity indicator came from what are known as satellite droplets. These are created when fast-travelling blood strikes the fabric, creating secondary stains around the central mark.
'The faster the blood was moving, the more satellite droplets there would be,' Fang added.
Certain cotton weaves told more of a story than others, however. Plain-woven cotton's physical properties were much easier to read, while twill proved more difficult.
'It's clear that the specific structures of each surface play a critical role in how these bloodstains form and what we can learn from them,' concluded Fang.
Researchers hope to conduct similar experiments on a wider range of fabrics, yarns, and weaves. Better understanding the interactions between these and other variables could help build a knowledge base that can then be applied to forensic crime scenes.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
NC-based app uses AI to fight denied health insurance claims
A new app developed in North Carolina is using artificial intelligence to fight denied health insurance claims. The app, from Counterforce, lets residents upload their insurance coverage documents along with their denial letter. ALSO READ: The cost of AI: Who pays to power the future? It then combines them to create a medically based analysis that residents can print and send back to their insurance company. Counterforce is free for anyone to use online. VIDEO: The cost of AI: Who pays to power the future?
Yahoo
44 minutes ago
- Yahoo
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July 28, 2025 at 8:00 AM ET to disclose the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial. Webcast and Conference Call Information The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to participate may access the live webcast here, or register in advance for the teleconference here. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company's lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PAM pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3Kα, AKT, or mTORC1 alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients. A Phase 1/2 clinical trial, CELC-G-201, evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing. A Phase 3 clinical trial, VIKTORIA-2, evaluating gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer is currently enrolling patients. More detailed information about Celcuity's active clinical trials can be found at Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at Follow us on LinkedIn and X. View source version of release on Contacts: Celcuity Inc. Brian Sullivan, bsullivan@ Vicky Hahne, vhahne@ (763) 392-0123 ICR HealthcarePatti Bank, (415) 513-1284Sign in to access your portfolio


TechCrunch
an hour ago
- TechCrunch
Meta names Shengjia Zhao as chief scientist of AI superintelligence unit
Meta CEO Mark Zuckerberg announced Friday that former OpenAI researcher Shengjia Zhao will lead research efforts at the company's new AI unit, Meta Superintelligence Labs (MSL). Zhao contributed to several of OpenAI's largest breakthroughs, including ChatGPT, GPT-4, and the company's first AI reasoning model, o1. 'I'm excited to share that Shengjia Zhao will be the Chief Scientist of Meta Superintelligence Labs,' Zuckerberg said in a post on Threads Friday. 'Shengjia co-founded the new lab and has been our lead scientist from day one. Now that our recruiting is going well and our team is coming together, we have decided to formalize his leadership role.' Zhao will set a research agenda for MSL under the leadership of Alexandr Wang, the former CEO of Scale AI who was recently hired to lead the new unit. We are excited to announce that @shengjia_zhao will be the Chief Scientist of Meta Superintelligence Labs! Shengjia is a brilliant scientist who most recently pioneered a new scaling paradigm in his research. He will lead our scientific direction for our team. Let's go 🚀 — Alexandr Wang (@alexandr_wang) July 25, 2025 Wang, who does not have a research banckground, was viewed as a somewhat unconventional choice to lead an AL lab. The addition of Zhao, who is a reputable research leader known for developing frontier AI models, rounds out the leadership team. To further fill out the unit, Meta has hired several high-level researchers from OpenAI, Google DeepMind, Safe Superintelligence, Apple, and Anthropic, as well as pulling researchers from Meta's existing FAIR and GenAI units. Zuckerberg notes in his post that Zhao has pioneered several breakthroughs, including a 'new scaling paradigm.' The Meta CEO is likely referencing Zhao's work on OpenAI's reasoning model, o1, in which he is listed as a foundational contributor alongside OpenAI co-founder Ilya Sutskever. Meta currently doesn't offer a competitor to o1, so AI reasoning models are a key area of focus for MSL. The Information reported in June that Zhao would be joining Meta Superintelligence Labs, alongside three other influential OpenAI researchers, including Jiahui Yu, Shuchao Bi, and Hongyu Ren. Meta has also recruited Trapit Bansal, another OpenAI researcher who worked on AI reasoning models with Zhao, as well as three employees from OpenAI's Zurich office that worked on multimodality. Zuckerberg has gone to great lengths to set MSL up for success. The Meta CEO has been on a recruiting spree to staff up his AI superintelligence labs, which has entailed sending personal emails to researchers and inviting prospects to his Lake Tahoe estate. Meta has reportedly offered some researcher eight and nine figure compensation packages, some of which are 'exploding offers' that expire in a matter of days. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW Meta has also upped its investment in cloud computing infrastructure, which should help MSL conduct the massive training runs required to create competitive frontier AI models. By 2026, Zhao and MSL's researchers should have access to Meta's one gigawatt cloud computing cluster, Prometheus, located in Ohio. Once online, Meta will be one of the first technology companies with an AI training cluster of Prometheus' size — one gigawatt is enough energy to power more than 750,000 homes. That should help Meta conduct the massive training runs required to create frontier AI models. With the addition of Zhao, Meta now has two chief AI scientists, including Yann LeCun, the leader of Meta's FAIR. Unlike MSL, FAIR is designed to focus on long-term AI research — techniques that may be used five to 10 years from now. How exactly Meta's three AI units will work together remains to be seen. Nevertheless, Meta now seems to have a formidable AI leadership team to compete with OpenAI and Google.